1. Health-Related Quality of Life in Patients with Hepatocellular Carcinoma Treated with Initial Transarterial Chemoembolization
   Jan B. Hinrichs et al, 2017, CardioVascular and Interventional Radiology CrossRef
2. Spontaneous Hepaticoduodenal and Choledochoduodenal Fistula Mimicking Duodenal Ulcer Perforation, a Very Rare Complication of Transarterial Chemoembolization
   Varayu Prachayakul et al, 2015, Case Reports in Gastroenterology CrossRef
3. Percutaneous Treatment of Localized Infiltrative Hepatocellular Carcinoma Developing on Cirrhosis
   Jean-Charles Nault et al, 2016, Annals of Surgical Oncology CrossRef
4. Efficacy and Safety of Transarterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma Associated with Bile Duct Tumor Thrombus: A Real-World Retrospective Cohort Study
   Jin-Kai Feng et al, 2021, Cancer Management and Research CrossRef
5. The Effect of Human Placental Extracts in Suppressing Tumor Cell and Preventing Normal Cell Damage
   Eiichi HIRANO et al, 2015, Japanese Journal of Complementary and Alternative Medicine CrossRef
6. Single-Center Comparison of Overall Survival and Toxicities in Patients with Infiltrative Hepatocellular Carcinoma Treated with Yttrium-90 Radioembolization or Drug-Eluting Embolic Transarterial Chemoembolization
   Joseph L. McDevitt et al, 2017, Journal of Vascular and Interventional Radiology CrossRef
7. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study
   Baolin Wu et al, 2018, World Journal of Surgical Oncology CrossRef
8. Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival
   Francesco Somma et al, 2019, PLOS ONE CrossRef
9. Hepatocellular Carcinoma: Review of Current Treatment with a Focus on Transarterial Chemoembolization and Radiofrequency Ablation
   Nikhar Chhaniwal et al, 2015, Open Journal of Radiology CrossRef
10. Transarterial Chemoembolization and 90Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease
    Nicholas Fidelman et al, 2015, American Journal of Roentgenology CrossRef
11. Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON study
    Fengyong Liu et al, 2017, Molecular Biology Reports CrossRef
12. Predicting Infiltrative Hepatocellular Carcinoma Patient Outcome Post-TACE: MR Bias Field Correction Effect on 3D-quantitative Image Analysis
    Cuihong Liu et al, 2020, Journal of Clinical and Translational Hepatology CrossRef
13. Management of hepatocellular carcinoma with portal vein thrombosis
    Matthew Quirk, 2015, World Journal of Gastroenterology CrossRef
14. Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety
    Zi-shu Zhang et al, 2019, BMC Cancer CrossRef
15. Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma
    Jie-Yu Kong et al, 2018, Medicine CrossRef
16. Evaluation of doxorubicin administrations in hepatocellular carcinoma in terms of genetic polymorphism, case study: Egypt
    Amina Tawfik et al, 2023, Arab Gulf Journal of Scientific Research CrossRef
17. Radiological appearance of hepatocellular carcinoma predicts the response to trans-arterial chemoembolization in patients undergoing liver transplantation
    Wei Zhang et al, 2019, BMC Cancer CrossRef